IVD Mergers and Acquisitions
Kalorama Information continously tracks mergers and acquisitons in the IVD market. This report IVD Mergers and Acquisitions, records and details 130 significant acquisitions that have taken place from 2012 to early 2015. Companies are the future of the industry lies in the development of more accurate, faster, usable devices. It also involves devices that are IT capable. It’s impossible for eve the largest companies to own all of the innovative technology, so M&A is an important part of strategy for diagnostic test makers.
In this report, mergers and acquisitions that are tracked are generally to achieve the following goals:
enter a new segment of the IVD market
counter a competitor
open a distribution channel
acquire a new IVD technology
This report tracks M&A activity for all of these purposes. This report’s coverage represents only a small portion of what is really happening in the market; more deals are still to come. Overall, uncertainty in reimbursement and healthcare reform in Europe and the U.S. have changed the acquisition landscape.
- ONE: EXECUTIVE SUMMARY
- Introduction
- Methodology
- TWO: IVD MERGERS AND ACQUISITIONS
- Introduction
- Major Developments
- Roche
- Thermo Fisher
- bioMérieux
- Becton Dickinson (BD)
- EKF Diagnostics
- Arkray
- Ortho Clinical Diagnostics
- Trends in Selected Segments
- Next Generation Sequencing Segment
- Tissue and Cell Diagnostics Segment
- Companion Diagnostics Segment
- Acquisitions That Played a Role in Product Development
- LIST OF EXHIBITS
- TWO: IVD MERGERS AND ACQUISITIONS
- Table 2-1: Selected Mergers and Acquisitions in the IVD Market, 2014 and 2015
- Table 2-2: Selected Diagnostics Industry Acquisitions, 2012 and 2013
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook